Nov 19, 2019 | Medicare Part D, Op-Ed
By Terry Wilcox Executive Director, Patients Rising Better health care was the top concern for 41 percent of voters in the midterm elections but Congress does not have to wait until next year to pass bipartisan health legislation. Among the must-pass bills for the...
Aug 6, 2019 | Drug Costs, Medicare Part D, News
Divided government, as a result of Democrats taking back the House of Representatives in last week’s election, means that almost all legislation will grind to a halt. This is especially true in today’s era of political polarization. But there is one Democratic policy...
Aug 6, 2019 | Medicare Part D, News
Better health care was the top concern for 41 percent of voters in the midterm elections, but Congress does not have to wait until next year to pass bipartisan health legislation. Among the must-pass bills for the 2018 lame duck session should be legislation that...
Aug 6, 2019 | Medicare Part D, News
In the wide ideological gulf between Democrat and Republican healthcare reform efforts — with “Medicare For All” at one end and a market-based system at the other — there has emerged one bipartisan point of agreement: Those with preexisting conditions must...
Aug 6, 2019 | Federal Issues, Issues, Medicare Part D, Out of Pocket Costs
The Issue Since 2003, the Medicare Part D drug benefit has provided prescription drug coverage to more than 44 million Americans, both seniors and those with disabilities.[1] This translates into one in eight Americans who now have access to a wide range of oral and...
Aug 6, 2019 | Medicare Part D, News
Patients Rising Now welcomes the proposed changes by the Trump Administration aiming to lower costs for patients by targeting backdoor rebates and encouraging direct discounts to those who receive their health care through Medicare/Medicaid. The current drug...
